The characteristics of food intake in patients with type II citrullinemia

Journal of Nutritional Science and Vitaminology

Volumn 57, Issue 3, 2011, Pages 239-245

  Nakamura, Mio ^a   Yazaki, Masahide ^b   Kobayashi, Yumiko ^a   Fukushima, Kazuhiro ^b   Ikeda, Shu Ichi ^b   Kobayashi, Keiko ^c   Saheki, Takeyori ^d   Nakaya, Yutaka ^e  

^a SHINSHU UNIVERSITY HOSPITAL   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

^d TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^e UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Adult onset type II citrullinemia (CTLN2); Low carbohydrate diet; PFC ratio

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CARBOHYDRATE INTAKE; CEREAL; CHILD; CITRULLINEMIA TYPE II; CLINICAL ARTICLE; CONTROLLED STUDY; FAT INTAKE; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; GENE MUTATION; HEPATIC ENCEPHALOPATHY; HUMAN; JAPANESE;

ADULT; AGE FACTORS; CALCIUM-BINDING PROTEINS; CASE-CONTROL STUDIES; CEREALS; CITRULLINEMIA; DIET; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY PROTEINS; ENERGY INTAKE; FOOD PREFERENCES; HEPATIC ENCEPHALOPATHY; HUMANS; JAPAN; MALE; MIDDLE AGED; ORGANIC ANION TRANSPORTERS; QUESTIONNAIRES;

EID: 80052758166     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.57.239     Document Type: Article

References (19)

1. 2+-stimulated aspartate/glutamate transporters in mitochondria. EMBO J 20: 5060-5069.
2. Kobayashi K, Sinasac DS, Iijima M, Boright AP, Begum L, Lee JR, Yasuda T, Ikeda S, Hirano R, Terazono H, Crackower MA, Kondo I, Tsui LC, Scherer SW, Saheki T. 1999. The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein. Nat Genet 22: 159-163.
3. Saheki T, Kobayashi K, Iijima M, Moriyama M, Yazaki M, Takei Y, Ikeda S. 2005. Metabolic derangements in deficiency of citrin, a liver-type mitochondrial aspartateglutamate carrier. Hepatol Res 33: 181-184.
4. Saheki T, Kobayashi K. 2002. Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis. J Hum Genet 47: 333-341.
5. Kobayashi K, Saheki T. 2004. Molecular basis of citrin deficiency. Seikagaku 76: 1543-1559 (in Japanese).
6. Takahashi H, Kagawa T, Kobayashi K, Hirabayashi H, Yui M, Begum L, Mine T, Takagi S, Saheki T, Shinohara Y. 2006. A case of adult-onset type II citrullinemia-deterioration of clinical course after infusion of hyperosmotic and high sugar solutions. Med Sci Monit 12: CS13-15.
7. Fukushima K, Yazaki M, Nakamura M, Tanaka N, Kobayashi K, Saheki T, Takei H, Ikeda S. 2010. Conventional diet therapy for hyperammonemia is risky in treatment of hepatic encephalopathy associated with citrin deficiency. Intern Med 49: 1-20.
8. Saheki T, Inoue K, Tushima A, Mutoh K, Kobayashi K. 2010. Citrin deficiency and current treatment concepts. Mol Genet Metab 100: S59-S64.
9. Saheki T, Kobayashi K, Terashi M, Ohura T, Yanagawa Y, Okano Y, Hattori T, Fujimoto H, Mutoh K, Kizaki Z, Inui A. 2008. Reduced carbohydrate intake in citrin-deficient subjects. J Inherit Metab Dis 31: 386-394.
10. Yasuda T, Yamaguchi N, Kobayashi K, Nishi I, Horinouchi H, Jalil MA, Li MX, Ushikai M, Iijima M, Kondo I, Saheki T. 2000. Identification of two novel mutations in the SLC25A13 gene and detection of seven mutations in 102 patients with adult-onset type II citrullinemia. Hum Genet 107: 537-545.
11. Yamaguchi N, Kobayashi K, Yasuda T, Nishi I, Iijima M, Nakagawa M, Osame M, Kondo I, Saheki T. 2002. Screening of SLC25A13 mutations in early and late onset patients with citrin deficiency and in the Japanese population: Identification of two novel mutations and establishment of multiple DNA diagnosis methods for nine mutations. Hum Mutat 19: 122-130.
12. Tabata A, Sheng JS, Ushikai M, Song YZ, Gao HZ, Lu YB, Okumura F, Iijima M, Mutoh K, Kishida S, Saheki T, Kobayashi K. 2008. Identification of 13 novel mutations including a retrotransposal insertion in SLC25A13 gene and frequency of 30 mutations found in patients with citrin deficiency. J Hum Genet 53: 534-545.
13. Soeda J, Yazaki M, Nakata T, Miwa S, Ikeda S, Hosoda W, Iijima M, Kobayashi K, Saheki T, Kojiro M, Miyagawa S. 2008. Primary liver carcinoma exhibiting dual hepatocellular-biliary epithelial differentiations associated with citrin deficiency: a case report and review of the literature. J Clin Gastroenterol 42: 855-860.
14. Kobayashi K, Horiuchi M, Saheki T. 1997. Pancreatic secretory trypsin inhibitor as a diagnostic marker for adult-onset type II citrullinemia. Hepatology 25: 1160-1165.
15. Takahashi K, Yoshimura Y, Kaimoto T, Kunii D, Komatsu T, Yamamoto S. 2001. Validation of a Food Frequency Questionnaire Based on Food Groups for Estimating Individual Nutrient Intake. Jpn J Nutr Diet 59: 221-232 (in Japanese).
16. Yazaki M, Takei Y, Kobayashi K, Saheki T, Ikeda S. 2005. Risk of worsened encephalopathy after intravenous glycerol therapy in patients with adult-onset type II citrullinemia (CTLN2). Intern Med 44: 188-195.
17. Saheki T, Iijima M, Li MX, Kobayashi K, Horiuchi M, Ushikai M, Okumura F, Meng XJ, Inoue I, Tajima A, Moriyama M, Eto K, Kadowaki T, Sinasac DS, Tsui LC, Tsuji M, Okano A, Kobayashi T. 2007. Citrin/mitochondrial glycerol 3-phosphate doubleknockout mice recapitulate features of human citrin deficiency. J Biol Chem 282: 25041-25052.
18. Imamura Y, Kobayashi K, Shibatou T, Aburada S, Tahara K, Kubozono O, Saheki T. 2003. Effectiveness of carbohydrate-restricted diet and arginine granules therapy for adult-onset type II citrullinemia: a case report of siblings showing homozygous SLC25A13 mutation with and without the disease. Hepatol Res 26: 68-72.
19. Dimmock D, Kobayashi K, Iijima M, Tabata A, Wong LJ, Saheki T, Lee B, Scaglia F. 2007. Citrin deficiency: a novel cause of failure to thrive that responds to a high protein, low carbohydrate diet. Pediatrics 119: 773-777.